Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
Blood samples will be tested to identify circulating tumor DNA and plasma protein levels to potentially improve prediction of long term prognosis and guide treatment options of patients with hepatocellular carcinoma underwent surgical resection.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients with a first diagnosis of HCC.
• Patients with HCC who are to undergo surgical treatment, with or without neoadjuvant therapy.
• Ability to obtain tissue sample for ctDNA analysis and detectable baseline ctDNA level.
Locations
Other Locations
China
Zhongshan Hospital Fudan University
RECRUITING
Shanghai
Contact Information
Primary
Huichuan Sun
sun.huichuan@zs-hospital.sh.cn
+86-21-64041990
Time Frame
Start Date: 2024-05-15
Estimated Completion Date: 2026-05-20
Participants
Target number of participants: 240
Related Therapeutic Areas
Sponsors
Leads: Shanghai Zhongshan Hospital